The Price Affair Is a Dark Horse Corruption Scandal Just Waiting to Erupt

Joshua Roberts/Reuters via ZUMA

Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily.


It’s been previously reported that HHS Secretary Tom Price has made some questionable stock trades that appear to be based on inside information he had as a congressman. But Robert Faturechi reports that there’s more:

On the same day the stockbroker for then-Georgia Congressman Tom Price bought him up to $90,000 of stock in six pharmaceutical companies last year, Price arranged to call a top U.S. health official, seeking to scuttle a controversial rule that could have hurt the firms’ profits and driven down their share prices, records obtained by ProPublica show.

….On March 17, 2016, Price’s broker purchased shares worth between $1,000 and $15,000 each in Eli Lilly, Amgen, Bristol-Meyers Squibb, McKesson, Pfizer and Biogen….The same day as the stock trade, Price’s legislative aide, Carla DiBlasio, emailed health officials to follow up on a request she had made to set up a call with Patrick Conway, the agency’s chief medical officer. In her earlier emails, DiBlasio said the call would focus on payments for joint replacement procedures. But that day, she mentioned a new issue.

“Chairman Price may briefly bring up … his concerns about the new Part B drug demo, as well,” she wrote. “Congressman Price really appreciates the opportunity to have an open conversation with Dr. Conway, so we really appreciate you keeping the lines of communication open.”

The “Part B drug demo” refers to a proposed Obama rule that removed the incentive for doctors to prescribe expensive drugs that don’t seem to improve patient outcomes. As it happens, there were plenty of folks in Congress from both parties who opposed this rule, so Price’s opposition wasn’t unusual. The difference is that all the others didn’t buy lots of pharmaceutical stock at the same time they were lobbying to stop a rule that might have eaten into pharmaceutical profits.

So far, the Price affair hasn’t attracted all that much attention. There are too many other Trump administration scandals to worry about. But this one has a decent chance of blowing up one of these days.

Don’t just click away.

We need your help. We’re halfway through our Summer Membership Drive, and only $35,000 toward our $200,000 goal. But there’s good news: This week only, every donation will be doubled, up to $50,000, thanks to a generous reader.

That’s twice the impact for intrepid reporting that peels back the layers to publish the truth—and the context you need to break it all down. It’s twice the fuel for investigations on voting rights and justice, critical in this midterm election year. And it’s twice the power for exposing the chaos and corruption of a White House trying to control the narrative.

This is a pivotal moment in our nation, with democracy on the line, and we can only do this work because readers like you step up. Every donation, of any amount, makes a difference here. And every donation will be doubled.

We cannot do this work without you. Join the fight. Double your donation to defend democracy.

Don’t just click away.

We need your help. We’re halfway through our Summer Membership Drive, and only $35,000 toward our $200,000 goal. But there’s good news: This week only, every donation will be doubled, up to $50,000, thanks to a generous reader.

That’s twice the impact for intrepid reporting that peels back the layers to publish the truth—and the context you need to break it all down. It’s twice the fuel for investigations on voting rights and justice, critical in this midterm election year. And it’s twice the power for exposing the chaos and corruption of a White House trying to control the narrative.

This is a pivotal moment in our nation, with democracy on the line, and we can only do this work because readers like you step up. Every donation, of any amount, makes a difference here. And every donation will be doubled.

We cannot do this work without you. Join the fight. Double your donation to defend democracy.

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

INDEPENDENT. BECAUSE OF YOU.

Mother Jones has no billionaires calling the shots—just readers like you making fearless reporting possible

Donate